Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.ACS Medicinal Chemistry Letters|April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)Catherine White, Meredeth A McGowan, Hua Zhou, et al.Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2016
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Guowei Zhou, Craig A Coburn, et al.Bioorganic & Medicinal Chemistry Letters|March 4, 2017
Discovery of novel BTK inhibitors with carboxylic acidsXiaolei Gao, James Wang, Jian Liu, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitorsWensheng Yu, Yongqi Deng, Brett Hopkins, et al.Journal of Medicinal Chemistry|November 4, 2016
Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated PolymorphismsLing Tong, Wensheng Yu, Lei Chen, et al.Pageof 13